Jennifer Ying Lan
Lawyers
Filters
Magenta Therapeutics, Inc. $64.8 Million Follow-On Offering of Common Stock
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8 million follow-on offering of common stock of Magenta Therapeutics,…
TransMedics Group, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its $250 Million Notes Reopening
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $250 million aggregate principal amount of its 4.375% senior notes due 2029. The…
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its €1.1 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. (MMC) in connection with its SEC-registered offering of €550 million aggregate principal amount of its 1.349% senior notes due 2026…
Davis Polk Advises Marsh & McLennan Companies on Its $5 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…
Davis Polk Advises S.A.C.I. Falabella on Its $550 Million Global Equity Offering
Davis Polk advised S.A.C.I. Falabella in connection with an offering by S.A.C.I. Falabella and Los Olivos Inversiones S.A., a controlling shareholder of S.A.C.I. Falabella, of 49,669,211…
Davis Polk Advises Tyson Foods on Its $900 Million Senior Notes Offerings
Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…
Zai Lab Limited $150 Million Follow-On Offering of American Depositary Shares
Davis Polk advised Zai Lab Limited in connection with its first follow-on offering of $150 million of American Depositary Shares representing 7,500,000 ordinary shares of the company. The…
Magenta Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $100 million initial public offering of common stock of Magenta…
Charah Solutions, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of Charah Solutions, Inc., which consisted of 7,352,941 shares of…